Collaborative Research Development Grant
Launched in 2004, this grant provides funds for large ovarian cancer research projects that involve several investigators within one institution or collaborations between groups in multiple institutions. Support of $300,000 annually for three years will be awarded to the institution(s) in which the recipients will conduct the research.
2023 Grant Recipients
- Daniel Heller, PhD, Memorial Sloan Kettering Cancer Center Perception-Based Detection of an Ovarian Cancer Disease Fingerprint
- Shayan Shams, PhD, Employing AI to Predict Clinical Outcomes in Ovarian Cancer
- Kristopher Sarosiek, PhD, Targeting Apoptotic Vulnerabilities in Ovarian Cancer
- Simon Gayther, PhD, Cedars-Sinai Medical Center iPSC Modeling of Ovarian Cancers in BRCA1 & 2 Mutation Carriers
2022 Grant Recipients
- Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center Inferring Mutational Processes and Patient Stratification From Standard-of-Care Clinical Imaging
- Jen-Tsan Chi, MD, PhD, Duke University The Role of Ferroptosis in the Metastatic Ovarian Cancer
- Ronald Buckanovich, MD, PhD, Magee-Womens Research Institute Role of Macrophage-secreted BIGH3 in Tumor Immunity
- Benjamin Bitler, PhD, University of Colorado - Denver A Machine Learning Approach to Chemotherapy-induced Remodeling of the Tumor
2021 Grant Recipients
- Martin Cannon, PhD, University of Arkansas for Medical Sciences Understanding and Targeting Myeloid Populations in Ovarian Cancer
- Ivan Ahel, PhD, University of Oxford Exploiting PARP-Modulating Enzymes in Ovarian Cancer Therapy
2020 Grant Recipients
- Andrew K. Godwin, PhD, University of Kansas Medical Center Research Institute Tumor-Derived Extracellular Vesicle in Ovarian Cancer
- Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center Profiling Co-Evolution of Ovarian Cancer and its Immune Microenvironment
- Ugo Cavallaro, PhD, Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Fondazione Monzino Interplay Between Ovarian Cancer Stem Cells and the Tumor Microenvironment
- Sandra Orsulic, PhD, UCLA School of Medicine Co-Evolution of Epithelial Ovarian Cancer and Tumor Stroma
2019 Grant Recipients
- Ronald Buckanovich, MD, PhD, Magee-Womens Research Institute Targeting Tumor Desmoplasia to Enhance Immunotherapy
- Rugang Zhang, PhD, The Wistar Institute Developing Epigenetic Therapies for Ovarian Cancer
2018 Grant Recipients
- Gordon Mills, MD, PhD, MD Anderson Cancer Center Rational Combination Therapy in Ovarian Cancer
- David Sabatini, MD, PhD, Whitehead Institute for Biomedical Research A Personalized Approach to Identify and Target Ovarian Cancer Liabilities
2017 Grant Recipients
- Tyler Curiel, MD, University of Texas Health Science Center at San Antonio Rational Design of Effective Multi-modal Ovarian Cancer Immunotherapy
- Ronen Marmorstein, PhD, University of Pennsylvania Chromatin Regulatory Mechanisms in Ovarian Cancer
- Kenneth Nephew, PhD, Indiana University Epigenetic Vulnerabilities of Ovarian Cancer Stem Cells
- Ie-Ming Shih, MD, PhD, Johns Hopkins University School of Medicine Development of Targeted Therapies for Recurrent Ovarian Cancer
2016 Grant Recipients
- Beth Y. Karlan, MD, Cedars-Sinai Medical Center Co-Evolution of Epithelial Ovarian Cancer and Tumor Stroma
- David Spriggs, MD, Memorial Sloan Kettering Cancer Center Novel Approaches to Immunotherapy
2015 Grant Recipients
- Anna Lokshin, PhD, University of Pittsburgh Microenvironmental Control of Premalignant Lesions in Ovarian Cancer
- Alexander Nikitin, MD, PhD, Cornell University Cancer-prone Stem Cell Niches in Ovarian and Tubal Epithelia
- Michael Yaffe, MD, PhD, Massachusetts Institute of Technology Using Functional Genetics and Nanomedicine for Ovarian Cancer Treatments
2014 Grant Recipients
- Tyler Curiel, MD, University of Texas Health Science Center at San Antonio Rational Design of Effective Multi-modal Ovarian Cancer Immunotherapy
- Ronen Marmorstein, PhD, University of Pennsylvania Chromatin Regulatory Mechanisms in Ovarian Cancer
- Ursula Matulonis, MD, Dana Farber Cancer Institute Rational Combinations of Novel Biologic Agents for Ovarian Cancer Therapy
2013 Grant Recipients
- Simon Gayther, PhD, University of Southern California Functional Analysis of Genetic Susceptibility Loci to Identify Biomarkers and Candidate Genes Associated with Ovarian Cancer Initiation, Progression and Outcome
- Anil K. Sood, MD, MD Anderson Cancer Center Power of Platelets in Ovarian Cancer
- Elizabeth Swisher, MD, University of Washington The FA-BRCA Pathway and Response to Platinum and PARP Inhibitors in Ovarian, Tubal and Peritoneal Carcinomas
2012 Grant Recipients
- George Coukos, M.D., Ph.D., University of Pennsylvania Engineering Immune Cells to Better Recognize and Kill Ovarian Cancer
- Ernst Lengyel, MD, PhD, University of Chicago Reprogramming of Ovarian Cancer Microenvironments by miRNAs
- Martin Matthew Matzuk, MD, PhD, Baylor College of Medicine Diagnostic Strategies for Detection of Ovarian Cancer
2011 Grant Recipients
- Kenneth Nephew, PhD, Indiana University A New Approach to Treating Recurrent Ovarian Cancer and Newly Diagnosed Disease
- Santo Nicosia, MD, University South Florida Ovarian Cancer: A Theme Based Approach Toward Identification of Novel Diagnostic and Therapeutic Targets
- Weiping Zou, MD, PhD, University of Michigan - Ann Arbor Understanding how Ovarian Cancer Stem Cells Play a Role in Disease Progression and Drug Resistance
2009 Grant Recipients
- Andrew Berchuck, MD, Duke University Medical Center International Ovarian Cancer Association Consortium: Finding Genetic Markers of Ovarian Cancer Using Polymorphisms
- Andrew K. Godwin, PhD, Fox Chase Cancer Center Understanding the Microenvironment Where Ovarian Cancer Grows as a Target for Treatment
- Anil K. Sood, MD, MD Anderson Cancer Center Novel Treatments for Ovarian Cancer Using siRNAs
2008 Grant Recipients
- Gary Leiserowitz, MD, University of California - Davis The Carbohydrate Components of Cellular Molecules: A New Way to Diagnose Ovarian Cancer?
- George Coukos, M.D., Ph.D., University of Pennsylvania Engineering T Cells to Augment Natural Immunity to Ovarian Cancer
- Robert C. Bast Jr., MD, MD Anderson Cancer Center Autophagy and Ovarian Cancer
2007 Grant Recipients
- Kunle Odunsi, MD, PhD, Roswell Park Cancer Institute Enhancing Immunity to Ovarian Cancer Tumors
- Martin Matthew Matzuk, MD, PhD, Baylor College of Medicine MicroRNA’s as Diagnostic and Therapeutic Targets in Ovarian Cancer
- Jonathan S. Berek, MD, MMS, Stanford University Leading the Effort to Develop Vaccines and Immunotherapy for Ovarian Cancer
2006 Grant Recipients
- Bo Rueda, PhD, Massachusetts General Hospital Understanding the Key Molecular Pathways that Drive Ovarian Cancer
- Peter Laird, PhD, University of Southern California/Keck Medical School Molecular Changes to DNA that Contribute to Ovarian Cancer
- Ronny I. Drapkin, MD, PhD, Dana Farber Cancer Institute Ovarian Cancer Biomarkers: Identification, Validation and Assessment of Biological Function
2005 Grant Recipients
- Anil K. Sood, MD, MD Anderson Cancer Center Novel siRNA Based Therapeutic Approaches for Ovarian Carcinoma
- Andrew K. Godwin, PhD, Fox Chase Cancer Center Therapeutic Targeting of the Tumor Microenvironment in Ovarian Cancer
- Andrew Berchuck, MD, Duke University Medical Center International Ovarian Cancer Association Consortium
2004 Grant Recipients
- Carol Aghajanian, MD, PhD, Memorial Sloan Kettering Cancer Center Novel Approaches to Ovarian Cancer Treatment